Editorial Policies
Advances in Therapy will endeavor to publish results from all well-designed and balanced studies in support of concerns raised in the GPP guidelines relating to publication bias.
Regarding authorship, Advances in Therapy refers to the guidelines of the International Committee of Medical Journal Editors (ICMJE, www.icmje.org). All individuals who do not meet the criteria for authorship should be listed in a Contributorship section at the end of the manuscript.
Advances in Therapy views medical writers as legitimate contributors and requests their roles and affiliations to be declared in the Contributorship section at the end of the manuscript, thereby ensuring transparency.
We request that personal, commercial, academic, or financial interests are also declared thereby ensuring transparency.
Advances in Therapy will publish data that has been pre-registered on clinical trial websites. We do ask, however, that if a trial registration number is available, it is included at the end of the abstract.
Presentation at scientific meetings (in the form of abstracts or posters) is not considered to constitute full publication. However, we ask that the manuscript makes reference to such presentation of the data.
To facilitate rapid publication, submissions to Advances in Therapy should conform to the standards outlined in the “Uniform Requirements for Manuscript submitted to Biomedical Journals,” prepared by ICMJE (www.icmje.org). Randomized controlled study reports should present information specified on the CONSORT checklist (available at: www.consort-statement.org).
